<?xml version="1.0" encoding="utf-8" ?>
<rss version="2.0">
<channel>
<title>Chinese Journal of Magnetic Resonance Imaging RSS feed</title>
<link>http://med-sci.cn/cgzcx/en/contents_list.asp?issue=202603</link>
<language>zh-cn</language>
<copyright>An RSS feed for Chinese Journal of Magnetic Resonance Imaging</copyright>
<item>
<title><![CDATA[Study on brain functional changes in patients with patent foramen ovale based on graph theory and independent component analysis]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.03.001</link>
<description><![CDATA[<b>Objective</b>To explore the abnormal changes in brain functional networks caused by patent foramen ovale (PFO) before the occurrence of structural lesions and the alterations in brain functional networks before and after PFO closure using functional magnetic resonance imaging (fMRI). <b>Materials and Methods</b>This study is a prospective study. Seventy-seven patients with PFO who were eligible for interventional occlusion in the Second Hospital of Hebei Medical University from October 2023 to October 2024 were selected and forty-two age- and gender-matched healthy controls (HC) were recruited from the community. The two groups are the PFO group and the HC group. All of them underwent fMRI examination. After six months of follow-up, twenty-four postoperative patients were collected and named as the postoperative group. The preoperative baseline data of these patients constituted the preoperative group. SPSS 25.0 software was used to analyze the gender, age and scale score data of the two groups. Using graph theory methods, based on the GRETNA software package in MATLAB R2013b, the whole-brain resting-state networks of two groups of patients were constructed and brain network analysis was performed. The results were analyzed by independent sample <i>t</i> test, and the preoperative and postoperative data were analyzed by paired sample <i>t</i> test. Independent component analysis (ICA) method was used to construct the resting-state networks (RSNs) of the whole brain and static functional network connectivity (sFNC) was used to evaluate the network connectivity strength of the whole brain. <b>Results</b>There was no statistically significant difference in gender and age between PFO group and HC group (<i>P</i> > 0.05). The Montreal Cognitive Assessment (MoCA) score of the PFO group was lower than that of the HC group, and the Visual Symptoms and Quality of Life Questionnaire (VSQ) score was higher than that of the HC group. The differences were statistically significant (<i>P</i> < 0.05). The small worldness (σ) and normalized clustering coefficient (γ) of the small world network in the PFO group were higher than those in the HC group. Normalized characteristic path length (λ), clustering coefficient (Cp) and characteristic path length (Lp) were lower than those in the HC group. The differences were statistically significant (<i>P</i> < 0.05). The global efficiency (E<sub>glob</sub>) of PFO group was higher than that of HC group. The differences were statistically significant (<i>P</i> < 0.05). There was no statistically significant difference in local efficiency (E<sub>loc</sub>) between PFO group and HC group (<i>P</i> > 0.05). Compared with the HC group, the PFO group showed enhanced sFNC in left fronto-parietal networks (LFPN) and sensory-motor network (SMN), and LFPN and dorsal attention network (DAN) (<i>P </i>< 0.05). The sFNC between SMN and VN, DAN and SMN, DAN and default mode network (DMN) decreased (<i>P </i>< 0.05). There was no statistically significant difference in gender and age between the PFO group and the postoperative group (<i>P</i> > 0.05). There was no statistically significant difference in cognitive assessment between the preoperative group and the postoperative group (<i>P</i> > 0.05). The postoperative Visual Analogue Scale (VAS) score of the subjects was lower than the preoperative score and the postoperative VSQ score was also lower than the preoperative score. The differences were statistically significant (<i>P </i>< 0.05). There was no significant difference in the values of brain network properties between the preoperative group and the postoperative group (<i>P</i> > 0.05). The sFNC of DAN-VN increased after closure (<i>P </i>< 0.05). <b>Conclusions</b>The changes of brain network characteristic values in PFO patients indicate that the stability of brain network is impaired, and the dynamic regulation of brain networks tends to increase compensatory communication efficiency. The functional connectivity of brain network in PFO patients is changed, which may be related to cognitive, visual abnormalities or headache symptoms. The enhancement of sFNC in some brain networks after surgery may be related to the recovery of brain function. ]]></description>
<pubDate>Fri,20 Mar 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[MPRAGE combined with rs-fMRI in the study of brain damage in patients with type 2 diabetes mellitus and prediabetes]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.03.002</link>
<description><![CDATA[<b>Objective</b>This study combined magnetization prepared rapid gradient echo (MPRAGE) with resting-state functional magnetic resonance imaging (rs-fMRI) to investigate the differences in resting-state gray matter volume and functional connectivity (FC) between patients with type 2 diabetes mellitus (T2DM) and prediabetes mellitus (PreDM), as well as the correlation between statistically significant brain region imaging markers and neuropsychological scale scores. <b>Materials and Methods</b>From July 2023 to December 2024,32 T2DM patients, 13 PreDM patients, and 30 individuals with normal glucose tolerance (NGT) were enrolled from the First Affiliated Hospital of Xinjiang Medical University. The gray matter volume differences among the three groups were analyzed, and brain regions with statistically significant gray matter volume differences were selected as seed points for FC analysis. The correlation between statistically significant brain regions in PreDM and T2DM patients and neuropsychological scale scores was also examined. <b>Results</b>(1) Gray matter volume [GRF (Gaussian random field correction), voxel level <i>P </i>&lt; 0.001, cluster level <i>P </i>&lt; 0.05]. Compared with the NGT group, the T2DM group showed reduced gray matter volume in the left middle temporal gyrus and left medial suprachiasmatic gyrus, while the PreDM group exhibited reduced gray matter volume in the left inferior frontal gyrus. Compared with PreDM, the T2DM group showed increased gray matter volume in the left inferior frontal gyrus. (2) FC (GRF, voxel level <i>P </i>&lt; 0.01, cluster level <i>P </i>&lt; 0.05). For the left middle temporal gyrus as the seed point, the FC analysis revealed statistically significant differences among the three groups in the right cerebellar area 6, right suboccipital gyrus, left middle frontal gyrus, left parietal gyrus, and left central anterior gyrus. Compared with the NGT group and PreDM group, the T2DM group showed increased FC values in these regions. Compared with the NGT group, the PreDM group exhibited decreased FC values in the right suboccipital gyrus. For the left medial suprachiasmatic gyrus as the seed point, the FC analysis revealed statistically significant differences among the three groups in the right precuneus and bilateral angular gyrus. Compared with the NGT group, the T2DM group showed increased FC values in the right precuneus. Compared with the PreDM group, the T2DM group exhibited increased FC values in both the right precuneus and bilateral angular gyrus. Compared with the NGT group, the PreDM group showed significantly decreased FC values in the bilateral angular gyrus. (3) Correlation analysis. The functional connectivity (FC) values between the left middle temporal gyrus and right suboccipital gyrus in the T2DM group showed a negative correlation with Montreal Cognitive Assessment (MoCA) scores (<i>r </i>= -0.393, <i>P </i>= 0.032). <b>Conclusions</b>This study revealed alterations in gray matter volume and FC values in specific brain regions among pre-diabetic (PreDM) and T2DM patients. Additionally, correlations were observed between FC values in certain brain regions and MoCA scores. T2DM patients may exhibit compensatory mechanisms, including increased FC values and reduced brain volume, as well as neurocompensatory mechanisms. These findings provide neuroimaging evidence for the early identification and intervention of cognitive impairment in diabetic patients. ]]></description>
<pubDate>Fri,20 Mar 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Value of diffusion weighted imaging-based habitat analysis for assessing isocitrate dehydrogenase mutation status in adult diffuse gliomas]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.03.003</link>
<description><![CDATA[<b>Objective</b>To investigate the diagnostic value of diffusion weighted imaging (DWI)-based habitat imaging for the preoperative assessment of isocitrate dehydrogenase (IDH) mutation status in adult diffuse gliomas. <b>Materials and Methods</b>A total of 99 adult patients with diffuse gliomas (73 IDH wildtype and 26 IDH mutant) were retrospectively enrolled. Based on the intravoxel incoherent motion (IVIM) and diffusion kurtosis imaging (DKI) models, the perfusion fraction (f), true diffusion coefficient (D), and mean kurtosis (MK) parameters were calculated. K-means clustering was applied to voxel-wise data within the tumor volume of interest (VOI) to construct habitat maps, and the volumetric fraction of each habitat was quantified. Logistic regression was used to develop diffusion parameter model, habitat model, age model and integrated model. The performance of different models was evaluated using five-fold cross-validation. DeLong test was employed to compare the performance of the integrated model with that of the other models. <b>Results</b>The proportion of Habitat 1 (Hypercellular hypoperfusion hyperheterogeneous habitat) was higher in IDH wild-type gliomas compared with IDH mutant gliomas (0.56 ± 0.25 vs. 0.30 ± 0.20, <i>P </i>< 0.001), whereas the proportion of Habitat 2 (Hypocellular hypoperfusion hypoheterogeneous habitat) was lower (0.39 ± 0.25 vs. 0.64 ± 0.21, <i>P </i>< 0.001). DeLong test showed that the integrated model achieved the highest diagnostic performance [AUC = 0.902, 95% confidence interval (<i>CI</i>): 0.759 to 1.000]. Shapley additive explanations analysis indicated that age contributed most to model predictions, followed by the proportion of Habitat 1. <b>Conclusions</b>Habitat imaging based on IVIM and DKI parameters effectively reflects the intratumoral heterogeneity of gliomas. When combined with clinical characteristics, it enables accurate, noninvasive prediction of IDH mutation status, offering a promising imaging biomarker for preoperative molecular subtyping of gliomas. ]]></description>
<pubDate>Fri,20 Mar 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[An experimental study of intravoxel incoherent motion diffusion-weighted imaging for evaluating the therapeutic effects of bone marrow mesenchymal stem cell in a rat model of peripheral nerve injury]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.03.004</link>
<description><![CDATA[<b>Objective</b>To investigate the value of quantitative parameters derived from intravoxel incoherent motion (IVIM) imaging in evaluating the therapeutic effects of bone marrow mesenchymal stem cell (BMMSC) in a rat model of peripheral nerve injury. <b>Materials and Methods</b>Thirty-six Sprague-Dawley (SD) rats were randomly assigned to a BMMSC group or a phosphate-buffered saline (PBS) control group. Each group underwent magnetic resonance imaging, motor function assessment, and histological analysis at five time points: before the operation and 1, 2, 3, and 4 weeks after the operation. IVIM perfusion fraction (f) assessed nerve perfusion, while T2-weighted imaging (T2WI) and T2 mapping assessed edema. Toluidine blue staining and immunofluorescence were used to assess neural structural alterations. The sciatic function index (SFI) was employed to assess functional recovery. The expression of vascular endothelial cell-specific markers (CD31) and inflammatory factors (IL-1α, IL-10 and PPARγ) was evaluated by immunohistochemistry. <b>Results</b>IVIM-f recovery, myelin regeneration, and nerve fiber repair were all significantly better in the BMMSC group than in the control group (all <i>P </i>< 0.05). Immunohistochemical analysis showed lower IL-1α and higher IL-10 and PPARγ levels in the BMMSC group than in the control group (all <i>P </i>< 0.05). And the expression of CD31 was significantly increased in the BMMSC group (<i>P </i>< 0.05). Moreover, the IVIM-f was closely correlated with both histopathological and functional outcomes. <b>Conclusions</b>Quantitative IVIM parameters, particularly IVIM-f, can reflect perfusion recovery and nerve regeneration earlier than T2 values after stem cell therapy in rats with peripheral nerve injury, and may serve as a potential imaging biomarker for evaluating the therapeutic efficacy of stem cell treatment. ]]></description>
<pubDate>Fri,20 Mar 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Differentiating pulmonary adenocarcinoma from inflammatory pulmonary masses using a multi-sequence MRI radiomics model]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.03.005</link>
<description><![CDATA[<b>Objective</b>To investigate the value of a multi-sequence MRI-based radiomics model in differentiating pulmonary adenocarcinoma from inflammatory pulmonary masses. <b>Materials and Methods</b>A retrospective analysis was conducted on 136 patients with pathologically confirmed lung adenocarcinoma and inflammatory pulmonary masses, whose clinical and MRI imaging data were collected for evaluation. All patients were randomly divided into a training set (<i>n </i>= 96) and a test set (<i>n </i>= 40) in a 7∶3 ratio. Through univariate and multivariate logistic regression analyses, indicators with discriminatory significance (<i>P </i>&lt; 0.05) in the clinical and MRI features of patients with lung adenocarcinoma and inflammatory lung occupying lesions were screened. Tumor regions of interest (ROI) were delineated on four sequence images: T1-weighted imaging (T1WI), T2-weighted imaging (T2WI), apparent diffusion coefficient (ADC) maps, and dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI). Radiomics features were then extracted using PyRadiomics. Highly correlated redundant features were removed based on the Spearman correlation coefficient. Subsequently, the remaining features were screened using ten-fold cross-validation and the least absolute shrinkage and selection operator (LASSO). Logistic regression (LR) was then applied to construct single-sequence and combined multi-sequence radiomics models. Model performance was evaluated using the receiver operating characteristic (ROC) curve and the area under the curve (AUC), based on which the optimal radiomics model was selected. Finally, clinical, clinical-imaging, and clinical-imaging-radiomics combined model were developed by integrating clinical features, MRI features, and the optimal radiomics model, and a visual nomogram was constructed. Statistical comparison of AUCs was performed using the DeLong test, and the clinical utility of the models was assessed via decision curve analysis (DCA). <b>Results</b>Age, smoking history, straightening sign, ADC value, and time-intensity curve (TIC) type were identified as independent predictors for pulmonary adenocarcinoma (<i>P</i> &lt; 0.05). Among the radiomics models, the multi-sequence MRI (T1WI+T2WI+ADC+DCE-MRI) model achieved the best diagnostic performance, with AUCs of 0.888 and 0.738 in the training and test sets, respectively. Further integration of clinical, MRI, and radiomics features yielded a combined model, analysis of which showed that the combined model had higher predictive performance (<i>P </i>&lt; 0.05), with AUCs reaching 0.924 and 0.853 in the training and test sets, respectively. <b>Conclusions</b>The combined model based on clinical, MRI features, and multi-sequence MRI radiomics shows good diagnostic efficacy in differentiating pulmonary adenocarcinoma from inflammatory pulmonary masses. ]]></description>
<pubDate>Fri,20 Mar 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Intravoxel incoherent motion histogram parameters combined with clinical features to predict the response of neoadjuvant therapy in patients with rectal cancer]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.03.006</link>
<description><![CDATA[<b>Objective</b>To explore the predictive value of intravoxel incoherent motion (IVIM) histogram parameters combined with clinical features for pathologic complete response after neoadjuvant therapy in patients with locally advanced rectal cancer. <b>Materials and Methods</b>Clinical and imaging data of 197 patients (training set: 130, validation set: 67) with rectal cancer who underwent neoadjuvant therapy and radical surgery in Sichuan Cancer Hospital from January 2019 to December 2025 were retrospectively analyzed. Patients were categorized into significantly response and non-significantly response groups based on postoperative pathological findings. The mean (Mean), median (Median), standard deviation (SD), maximum (Maximum), and variance (Variance) of the histogram parameters of true diffusion coefficient (D), pseudo diffusion coefficient (D<sup>*</sup>), and perfusion fraction (f) were obtained based on IVIM images. Multivariate logistic regression analyses was used to establish combined parameters model. The area under curve (AUC) of receiver operating characteristic, sensitivity, accuracy, and specificity were used to assess the diagnostic performance. DeLong test was used for comparisons of the AUCs among independent risk predictors and combined parameters model. <b>Results</b>The values of f<sub>Mean</sub>, f<sub>Median</sub>, f<sub>SD</sub>, f<sub>Maximum</sub>, f<sub>Variance</sub>, D<sup>*</sup><sub>Mean</sub>, D<sup>*</sup><sub>Median</sub>, D<sup>*</sup><sub>SD</sub>, and D<sup>*</sup><sub>Variance</sub> were significantly higher in the significantly response group compared with the non-significantly response group in the training set (all <i>P</i> &lt; 0.05). No significant difference were found in the D values between the two groups (all <i>P</i> &gt; 0.05). The AUC of combined parameters model combing four independent risk factors was 0.894 [95% confidence interval (<i>CI</i>): 0.827 to 0.941] and 0.831 (95% <i>CI</i>: 0.714 to 0.928) in the training set and validation set, respectively, which was significantly higher than any other independent risk factors according to DeLong test (all <i>P</i> &lt; 0.05). The accuracy, sensitivity and specificity of the combined parameters model was 0.854 (95% <i>CI</i>: 0.781 to 0.909), 0.711 (95% <i>CI</i>: 0.541 to 0.845), 0.913 (95% <i>CI</i>: 0.835 to 0.961) and 0.806 (95% <i>CI</i>: 0.701 to 0.896), 0.731 (95% <i>CI</i>: 0.522 to 0.884), 0.854 (95% <i>CI</i>: 0.708 to 0.944) in the training set and validation set, respectively. <b>Conclusions</b>IVIM histogram parameters can provide some basis for predicting the efficacy of neoadjuvant therapy in patients with rectal cancer, and the diagnostic efficacy of the model can be improved after further combining clinical features. ]]></description>
<pubDate>Fri,20 Mar 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[The value of deep learning models based on multiparameter MRI in the preoperative prediction of tumor deposits in rectal cancer]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.03.007</link>
<description><![CDATA[<b>Objective</b>To investigate the value of deep learning (DL) models based on multiparametric MRI, including diffusion-weighted imaging (DWI), fat-suppressed T2-weighted imaging (T2-FS), and T1-weighted contrast-enhanced imaging (T1CE), in preoperatively predicting tumor deposit (TD) status in rectal cancer. <b>Materials andMethods</b>A retrospective analysis was conducted on 321 patients from two centers who underwent total mesorectal excision and were pathologically diagnosed with rectal adenocarcinoma. Patients were divided into a TD-positive group (<i>n </i>= 81) and a TD-negative group (<i>n </i>= 240) based on pathology. Patients from center 1 (<i>n </i>= 273) were randomly split 8∶2 into a training set and a test set, while patients from center 2 (<i>n </i>= 48) served as an external validation set. Using the ResNet18 DL network, four models were built: a DWI-DL model, a T2-FS-DL model, a T1CE-DL model, and a combined-DL model. Receiver operating characteristic (ROC) curves were plotted, and the area under the curve (AUC) was calculated to evaluate the predictive performance of each DL model. <b>Results</b>In the single-sequence models, the T1CE-DL model achieved AUCs of 0.842 (95% <i>CI</i>: 0.808 to 0.891), 0.792 (95% <i>CI</i>: 0.752 to 0.828), and 0.747 (95% <i>CI</i>: 0.700 to 0.777) in the training, test, and external validation sets, respectively, demonstrating superior predictive performance compared to the T2-FS-DL and DWI-DL models. The T2-FS-DL model yielded AUCs of 0.805 (95% <i>CI</i>: 0.774 to 0.843), 0.766 (95% <i>CI</i>: 0.724 to 0.801), and 0.725 (95% <i>CI</i>: 0.690 to 0.767) in the three datasets, respectively. For the DWI-DL model, the AUCs were 0.801 (95% <i>CI</i>: 0.753 to 0.832), 0.745 (95% <i>CI</i>: 0.703 to 0.775), and 0.747 (95% <i>CI</i>: 0.702 to 0.779), respectively. The combined-DL model achieved the highest AUCs, reaching 0.909 (95% <i>CI</i>: 0.877 to 0.956), 0.875 (95% <i>CI</i>: 0.834 to 0.919), and 0.816 (95% <i>CI</i>: 0.767 to 0.852) in the training test, and external validation sets, respectively. Its diagnostic performance was significantly superior to that of the three single-sequence models (DeLong test, all <i>P</i> < 0.05). <b>Conclusions</b>The combined-DL model shows good predictive value and generalization ability for preoperatively assessing TD status in rectal cancer patients. ]]></description>
<pubDate>Fri,20 Mar 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Diagnostic value of magnetic resonance diffusion-weighted imaging for T-staging between T1 and T2 of bladder cancer: A Meta-analysis]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.03.008</link>
<description><![CDATA[<b>Objective</b>This study employed a meta-analysis approach to systematically evaluate the diagnostic performance of diffusion-weighted imaging (DWI) in staging bladder cancer, specifically in differentiating T1 or lower stages from T2 or higher stages. <b>Materials and Methods</b>A comprehensive literature search was conducted in CNKI, PubMed, and Embase databases (from the establishment to March 2025) using inclusion criteria. The quality assessment of diagnostic accuracy studies-2 (OUADAS-2) was used to assess the quality of the included studies. Heterogeneity testing was performed using RevMan 5.3 and Stata 18.0 statistical software. Meta-analysis of diagnostic sensitivity and specificity was conducted, with subsequent construction of summary receiver operating characteristic (SROC) curves and calculation of evaluation metrics including area under the curve (AUC). <b>Results</b>Twelve studies were included in the analysis. The pooled sensitivity of DWI for T-staging of bladder cancer was 0.89 [95% (confidence interval, <i>CI</i>): 0.78 to 0.95], specificity was 0.85 (95% <i>CI</i>: 0.77 to 0.90), AUC reached 0.92 (95% <i>CI</i>: 0.89 to 0.94), positive likelihood ratio (PLR) was 5.9 (95% <i>CI</i>: 3.9 to 8.8), negative likelihood ratio (NLR) was 0.13 (95% <i>CI</i>: 0.06 to 0.27), and diagnostic odds ratios (DOR) was 45 (95% <i>CI</i>: 19 to 109). Deek<sup><sup>,</sup></sup>s funnel plot was basically symmetrical, and the slope coefficient was not statistically significant (<i>P </i>= 0.44), suggesting that there was no significant publication bias in the studies included inour analysis. <b>Conclusions</b>DWI demonstrates high diagnostic value in T-staging of bladder cancer and provides crucial reference information for clinical treatment decision-making. ]]></description>
<pubDate>Fri,20 Mar 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[The value of blood oxygen level dependent MRI in assessing treatment response and prognostic risk factors in cervical squamous cell carcinoma undergoing neoadjuvant chemotherapy]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.03.009</link>
<description><![CDATA[<b>Objective</b>To investigate the value of the effective transverse relaxation rate (R2<sup>*</sup>) derived from blood oxygen level dependent magnetic resonance imaging (BOLD-MRI) in assessing the response to neoadjuvant chemotherapy (NACT) and prognostic risk factors in cervical squamous cell carcinoma. <b>Materials and Methods</b>This study retrospectively enrolled 64 patients with cervical squamous cell carcinoma who underwent surgery after NACT at our institution. All patients underwent BOLD-MRI before and after NACT. Tumor histopathological features, including lymph node metastasis (LNM), lymphovascular space invasion (LVSI), and depth of stromal invasion, were recorded based on postoperative pathology. According to Response Evaluation Criteria in Solid Tumors version 1.1 (RECIST 1.1), patients were classified into a partial response (PR) group (<i>n </i>= 54) and a stable disease (SD) group (<i>n </i>= 10). Inter-observer agreement was assessed using the intra-class correlation coefficient (ICC). The Mann-Whitney<i> U </i>test or independent samples <i>t</i>-test was used to compare R2<sup>*</sup> values between groups. To evaluate the predictive value and correlation of R2<sup>* </sup>parameters with tumor histopathological features and response to NACT, binary logistic regression and Pearson or Spearman correlation analysis were employed, respectively. Furthermore, receiver operating characteristic (ROC) curves were plotted to assess the predictive performance of R2<sup>*</sup> values, and internal validation was performed using the bootstrap method. <b>Results</b>Both post-NACT R2<sup>*</sup> (R2<sup>*</sup><sub>post</sub>) and the change in R2<sup>*</sup> (ΔR2<sup>*</sup>) demonstrated predictive value for LVSI, LNM, and depth of stromal invasion (all <i>P</i> < 0.05). Area under the ROC curve (AUC) analysis indicated that R2<sup>*</sup><sub>post</sub> exhibited superior predictive performance compared to ΔR2<sup>*</sup>for LVSI, stromal invasion depth, and prognostic risk factors (adjusted AUCs: 0.862 vs. 0.792, 0.742 vs. 0.687, and 0.749 vs. 0.699, respectively), with optimal cutoff values of 21.44 Hz, 21.68 Hz, and 21.68 Hz, respectively. In contrast, for LNM, ΔR2<sup>*</sup>showed better predictive efficacy than R2<sup>*</sup><sub>post </sub>(adjusted AUC: 0.792 vs. 0.738), with an optimal cutoff value of 1.145 Hz. Multivariate analysis further confirmed that R2<sup>*</sup><sub>post </sub>was an independent predictor of LVSI, and ΔR2<sup>* </sup>was an independent predictor of LNM. <b>Conclusions</b>R2<sup>*</sup><sub>post </sub>and ΔR2<sup>*</sup> may serve as potential imaging biomarkers for assessing treatment response to NACT and prognostic risk factors in cervical squamous cell carcinoma. Lower values of these parameters are associated with unfavorable clinical outcomes. ]]></description>
<pubDate>Fri,20 Mar 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Dynamic evolution of white matter injury following germinal matrix hemorrhage in neonatal rats: A longitudinal study based on diffusion tensor imaging]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.03.010</link>
<description><![CDATA[<b>Objective</b>To investigate the spatiotemporal progression of white matter injury following germinal matrix hemorrhage (GMH) using multimodal magnetic resonance imaging (MRI), and to explore the neuroinflammatory response and motor function outcomes. <b>Materials and Methods</b>A total of 38 postnatal day 5 Sprague-Dawley rats were randomly assigned to either a GMH group (induced by collagenase injection) or a sham-operated control group. Longitudinal MRI scans, including T2-weighted imaging (T2WI), susceptibility-weighted imaging (SWI), and diffusion tensor imaging (DTI), were performed at 12 hours, and 1, 3, 5, and 30 days post-surgery. Quantitative analysis of DTI parameters, fractional anisotropy (FA), mean diffusivity (MD), axial diffusivity (AD), and radial diffusivity (RD), was conducted in 7 regions of interest (ROI): the striatum, hippocampus, internal capsule, external capsule, corpus callosum, motor cortex, and somatosensory cortex. Acute neuroinflammation was assessed via Western blot (WB), quantitative real-time polymerase chain reaction (qRT-PCR), and immunohistochemistry (IHC). Long-term motor function was evaluated using the pole test. <b>Results</b>DTI analysis revealed significantly decreased FA values accompanied by increased MD and RD values in multiple brain regions in the GMH group, indicating compromised white matter integrity. FA values in the striatum declined significantly from 1 day post-GMH onward (<i>P</i> < 0.001), and this decrease was sustained through 30 days (<i>P</i> = 0.004), along with elevated MD and RD values (<i>P</i> < 0.05). In the hippocampus, FA values began to decline at 3 days post-GMH compared with controls (<i>P</i> < 0.05) and remained lower until 30 days (<i>P</i> < 0.05), with concurrent elevations in MD, AD, and RD (<i>P</i> < 0.05). By 30 days post-GMH, FA values in all seven ROIs on the injured side were significantly lower than those on the contralateral side (<i>P</i> < 0.05), indicating clear lateralization of white matter injury. Molecular analyses showed a significant upregulation of pro-inflammatory cytokines (IL-6, IL-1β, TNF-α; <i>P</i> < 0.001) and marked activation of both microglia and astrocytes during the acute phase post-GMH. Behavioral testing showed a significantly prolonged descent time in the pole test for the GMH group (<i>P</i> < 0.05), demonstrating a correlation between white matter structural damage and motor dysfunction. <b>Conclusions</b>DTI sensitively captures dynamic microstructural alterations in white matter following GMH. These structural alterations are significantly associated with neuroinflammatory responses and long-term motor deficits. Our findings provide crucial imaging evidence for understanding the underlying mechanisms of GMH pathology. ]]></description>
<pubDate>Fri,20 Mar 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Prospective randomized controlled animal intervention study on multi-dimensional characterization of microcirculation and tissue heterogeneity in rat acute pancreatitis based on Multi-parametric MRI]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.03.011</link>
<description><![CDATA[<b>Objective</b>Traditional imaging techniques provide limited diagnostic information regarding microcirculatory impairment and inflammatory burden in acute pancreatitis (AP). This study aimed to establish a multi-parametric magnetic resonance imaging (MRI)-based approach to characterize pancreatic injury in a rat model of AP. The predictive performance of contrast enhancement ratio (CR) and histogram parameters (Skewness and Kurtosis) was evaluated. In addition, we assessed whether these imaging biomarkers could sensitively capture the therapeutic effects of emodin in vivo. <b>Materials and Methods</b>Forty-five Sprague-Dawley (SD) rats were randomly assigned to the control (CN) group, an AP group and an emodin-treated  (ET) group (<i>n</i> = 15 per group). Using 3.0 T MRI to obtain enhanced T1WI images, and measuring the contrast ratio (CR), Skewness and Kurtosis of the images. At the same time, detecting the levels of serum amylase, lipase and creatinine, conducting histological scoring (HS), and determining the expression of inducible nitric oxide synthase (iNOS). Spearman rank correlation and multivariate regression analyses were conducted to determine the associations between imaging biomarkers and pathological criteria. Receiver operating characteristic (ROC) analysis was used to evaluate the performance of the imaging-based predictive model for AP severity. <b>Results</b>Compared with CN group, AP rats exhibited distinct MRI features characterized by an increase of CR and Skewness (both <i>P </i>< 0.001), along with decreased Kurtosis (<i>P </i>< 0.05). The three imaging indicators in the ET group were all improved compared with those in the AP group (<i>P</i> < 0.05), and the differences were statistically significant, approaching the levels of the CN group.  Correlation analysis demonstrated that CR was significantly and moderately to highly positively correlated with the positive expression levels of HS and iNOS (<i>ρ</i> = 0.64 to 0.85, <i>P</i> < 0.001), while Kurtosis was significantly negatively correlated with HS (<i>ρ</i> = -0.84, <i>P</i> < 0.001). Multivariate regression analysis demonstrated that CR was independently associated with HS and iNOS expression (<i>β</i> = 6.69, <i>P </i>< 0.05), whereas Kurtosis was negatively associated with HS (<i>β</i> = -2.56, <i>P </i>< 0.001). The combined CR and Kurtosis model achieved an AUC of 0.95 for predicting severe AP (HS ≥ 12), with an overall accuracy of 89.6%. CR alone yielded an AUC of 0.98 for predicting high iNOS expression. <b>Conclusions</b>CR, Skewness and Kurtosis enable non-invasive quantification of AP-related alterations in perfusion status and tissue heterogeneity. CR primarily reflects perfusion abnormalities, while Kurtosis more accurately indicates tissue heterogeneity. Emodin mitigates pancreatic injury by reducing inflammatory burden and improving microcirculatory perfusion. This multi-parametric MRI workflow provides a reliable imaging-based strategy for grading AP severity and monitoring therapeutic response. ]]></description>
<pubDate>Fri,20 Mar 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[A bibliometric and visual analysis of research dynamics in fMRI applied to mild cognitive impairment: Hotspots, frontiers, and trends]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.03.012</link>
<description><![CDATA[Early identification and intervention for mild cognitive impairment (MCI) are of great significance in delaying the progression of dementia. Functional magnetic resonance imaging (fMRI), with its advantages of non-invasiveness, reproducibility, and in vivo visualization of brain function, has become a core neuroimaging technique for exploring functional brain changes in MCI. This study retrieved relevant literature on the application of fMRI in MCI research from the Web of Science (WOS) Core Collection and the China National Knowledge Infrastructure (CNKI), covering the period from database inception to September 1, 2025. Using bibliometric methods, the software Citespace 6.1.R6 and VOSviewer 1.6.18 were employed to systematically reveal the global development trends, collaboration patterns, knowledge structure, research hotspots, and emerging frontiers in the field of fMRI research on MCI. A total of 4132 articles were included, comprising 4014 from WOS and 118 from CNKI. The annual number of publications showed a steady upward trend. In the WOS database, China ranked first in the number of publications (1684 articles, accounting for 41.95%, including 52 articles from the Taiwan region), while the United States had the highest citation count (74 881 citations). The number of publications in CNKI was relatively limited, indicating a need for improvement in both research quantity and quality. This review demonstrates that fMRI is widely applied in MCI research. Resting-state functional brain network analysis, multimodal imaging integration, and deep learning models represent current research hotspots and frontiers. Future efforts should focus on establishing interdisciplinary, cross-regional, and international collaborative networks to promote knowledge sharing and resource complementarity, thereby addressing core scientific challenges in the early diagnosis and intervention of MCI and fostering sustained innovation and high-quality development in this field. ]]></description>
<pubDate>Fri,20 Mar 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Advances in functional brain imaging research of post-traumatic stress disorder induced by different trauma types]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.03.013</link>
<description><![CDATA[Post-traumatic stress disorder (PTSD) is a highly heterogeneous psychiatric condition, and its underlying neural mechanisms are closely linked to the specific nature of the traumatic experience. Current research is limited by insufficient control over critical confounding factors, such as comorbidity, and the duration and frequency of trauma exposure. Future studies should prioritize rigorous measurement and statistical control of these variables in their design to more accurately delineate the neural effects attributable to trauma itself.This review systematically synthesizes and compares functional magnetic resonance imaging (fMRI) studies on PTSD resulting from distinct types of trauma, including war-related experiences, childhood maltreatment, sexual violence, traffic accidents, and natural disasters. We summarize the characteristic patterns of brain dysfunction associated with each trauma type and discuss their implications for developing a refined "trauma type–neural circuit–clinical phenotype" model. This work aims to provide a theoretical foundation for advancing the neurobiological subtyping of PTSD and fostering the development of individualized therapeutic interventions. ]]></description>
<pubDate>Fri,20 Mar 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Advances in MRI research on brain structural and functional networks in patients with lifelong premature ejaculation]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.03.014</link>
<description><![CDATA[Lifelong premature ejaculation (LPE) is a common male sexual dysfunction that severely impacts the quality of life of both patients and their partners. Previous research has largely focused on psychological factors and peripheral neural mechanisms. In recent years, with the advancement of multimodal MRI technology, scholars have gradually shifted their focus to the level of brain networks to gain deeper insights into the central neural mechanisms of LPE. This article reviews the progress of MRI studies on brain structural and functional networks in patients with LPE, systematically elucidating the role of brain networks in ejaculation modulation and emotional regulation, as well as their abnormal patterns. It further interprets the neural mechanisms of LPE as a brain network disorder, identifies current research limitations, and suggests future research directions. This review aims to provide a theoretical basis for the development of neural-targeted therapeutic strategies and the improvement of patients<sup><sup>,</sup></sup> sexual health. ]]></description>
<pubDate>Fri,20 Mar 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Research progress on MRI of the glymphatic system in mental disorders]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.03.015</link>
<description><![CDATA[In recent years, the discovery and further study of the glymphatic system (GS) has greatly advanced the field of neuroscience. The discovery of the GS has provided a new perspective on the mechanisms of metabolic waste removal in the central nervous system and fluid dynamics in the brain. When GS function is impaired, it can lead to the accumulation of neurotoxic substances such as amyloid-β (Aβ) and tau protein, as well as inflammatory mediators, interacting with sleep disturbances, neuroinflammation, and circadian rhythm disruptions, thereby influencing disease progression. The link between GS and disease originated in Alzheimer<sup><sup>,</sup></sup>s disease, and research has gradually expanded to other fields, with growing evidence indicating that GS dysfunction is involved in the pathophysiological processes of various psychiatric disorders. However, research on GS in psychiatric disorders is still in its early stages, and some diseases remain underexplored in this field. This review systematically outlines the structure, function, and influencing factors of the GS, summarizes current imaging techniques used to assess GS function, discusses the limitations of existing research, and provides future perspectives. It aims to offer new insights into the intrinsic relationship between GS function and psychiatric disorders, and to serve as a reference for further research in this area. ]]></description>
<pubDate>Fri,20 Mar 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Multimodal magnetic resonance imaging findings in depression with comorbid insomnia]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.03.016</link>
<description><![CDATA[Depression is a common mental disorder that imposes a substantial burden on individuals and society. Insomnia is one of the most prevalent and clinically persistent symptoms in depression and shows a close bidirectional relationship with its onset, progression, and outcome, often indicating greater symptom severity, poorer treatment response, and a higher risk of relapse. Accumulating evidence suggests that depression and insomnia may, at least in part, share overlapping neurobiological mechanisms. In recent years, the application of multimodal MRI has substantially advanced the investigation of the neural underpinnings of depression comorbid with insomnia. This review systematically summarizes recent findings from structural MRI (sMRI), diffusion tensor imaging (DTI), functional MRI (fMRI), arterial spin labeling (ASL), and magnetic resonance spectroscopy (MRS) studies in this field. We highlight converging evidence of alterations in gray matter structure, white matter microstructure, glymphatic system function, brain activity, functional connectivity, and neurochemical profiles in individuals with depression and comorbid insomnia. In addition, we discuss the limitations of the existing literature and outline directions for future research, with the goal of facilitating the identification of imaging-based biomarkers and informing precision medicine approaches in clinical practice. ]]></description>
<pubDate>Fri,20 Mar 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Advances in the application of AI-based MRI in depressive disorder]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.03.017</link>
<description><![CDATA[Depression is a highly prevalent and disabling mental disorder worldwide, imposing substantial health and economic burdens on patients, families, and society. Currently, its clinical diagnosis primarily relies on symptom-based assessments, which are inherently subjective and heterogeneous, thereby limiting early identification and precise intervention. In recent years, artificial intelligence (AI)-based approaches have provided new possibilities for leveraging multimodal neuroimaging data to assist in objective prediction, biomarker discovery, and personalized treatment of depression. However, significant challenges persist in this field, including high data heterogeneity, lack of multi-center external validation, reliance on retrospective single-center data, and poor model interpretability. This paper systematically reviews the current state of artificial intelligence technologies in multimodal imaging research on depression and highlights that future efforts should be directed toward advancing data standardization, model robustness, and ethical oversight, while simultaneously enhancing model generalizability, interpretability, and clinical translation. These endeavors aim to inform the development of AI-assisted early warning, precise diagnosis, and treatment decision-making for depression. ]]></description>
<pubDate>Fri,20 Mar 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Progress on diffusion magnetic resonance imaging in assessing brain cognitive functional changes in patients with obstructive sleep apnea]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.03.018</link>
<description><![CDATA[Obstructive sleep apnea (OSA) is a chronic disorder characterized by intermittent hypoxemia and sleep fragmentation as its core pathological features. It significantly increases the risk of cardiovascular events and metabolic syndrome, and also drives progressive degeneration of brain structure and cognitive function through oxidative stress and neurovascular unit impairment. The rapid advancement and innovation of diffusion magnetic resonance imaging (dMRI) techniques have provided critical tools for exploring the mechanisms of OSA-related brain injury. Among them, diffusion tensor imaging (DTI), based on diffusion weighted imaging (DWI), with its non-invasiveness, high resolution, and sensitivity to microstructural heterogeneity in white matter, has emerged as a cornerstone technology for elucidating OSA-associated neuropathology. Building on this foundation, emerging techniques such as diffusion kurtosis imaging (DKI), diffusion tensor imaging along the perivascular space (DTI-ALPS), and free-water diffusion tensor imaging (FW-DTI) have further expanded the scope of research. This article systematically reviews the impact of OSA on brain structure, network connectivity, glymphatic system function, and cognitive performance, with a focus on recent advancements in dMRI technologies and their clinical implications. It also points out the limitations of current studies and suggests directions for future research. ]]></description>
<pubDate>Fri,20 Mar 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Research progress of magnetic resonance imaging in predicting treatment efficacy for major depressive disorder]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.03.019</link>
<description><![CDATA[Major depressive disorder (MDD) is a prevalent, chronic, and relapsing mental illness. In recent years, both its incidence and suicide rates have risen steadily. The pathogenesis of MDD involves complex interactions among genetic, environmental, and neurobiological factors. Currently, efficacy assessment relies primarily on clinicians<sup><sup>,</sup></sup> experience and subjective rating scales, which hinders the advancement of personalized precision medicine. With the rapid development of magnetic resonance imaging (MRI), therapeutic outcomes can now be objectively evaluated using diverse imaging biomarkers, including brain structural volume, cortical thickness, white matter integrity, functional connectivity, and neurometabolite levels. However, previous studies have largely focused on unimodal approaches. Complicated by the high clinical heterogeneity of the disease, the predictive efficacy and reproducibility of various biomarkers remain controversial, making it difficult to directly guide personalized treatment decisions. This review systematically synthesizes the research progress of multi-modal MRI technologies in predicting treatment efficacy for MDD. It specifically addresses current research status, methodological limitations, and the impact of clinical heterogeneity. The aim is to provide theoretical insights and future directions for establishing robust imaging biomarkers to guide personalized treatment strategies for MDD. ]]></description>
<pubDate>Fri,20 Mar 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Advances in magnetic resonance imaging research on post-stroke depression]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.03.020</link>
<description><![CDATA[Post-stroke depression (PSD) is a prevalent and severe neuropsychiatric complication following stroke, which significantly compromises patients<sup><sup>,</sup></sup> functional recovery and quality of life. Current clinical assessment of PSD primarily relies on depression rating scales and medical history. However, these methods are limited by inherent subjectivity and challenges in early identification, and objective neuroimaging biomarkers remain scarce. Recent advancements in multimodal MRI have provided novel tools for the systematic characterization of brain structural, functional, and microstructural alterations associated with PSD. Nevertheless, existing findings are fragmented, and the interplay between different imaging modalities and their clinical translational value has not been systematically synthesized. By reviewing the research progress of structural MRI, functional MRI, diffusion MRI, and magnetic resonance spectroscopy (MRS) in PSD, this article highlights the potential of cross-scale multimodal integration in elucidating neural mechanisms and improving risk prediction. Furthermore, the current limitations and future directions of the field are analyzed. This review aims to provide a neuroimaging framework for objective assessment, biomarker exploration, and the development of precision intervention strategies for PSD. ]]></description>
<pubDate>Fri,20 Mar 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Diagnostic value and clinical application progress of multimodal PET-MRI in the prodromal stage of Parkinson<sup><sup>,</sup></sup>s disease]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.03.021</link>
<description><![CDATA[Parkinson<sup><sup>,</sup></sup>s disease (PD) is an age-related neurodegenerative disorder; early diagnosis and treatment are critical to slowing its progression. Although its prodromal stage offers a critical intervention window, conventional MRI lacks specificity, and no imaging gold standard exists for diagnosis. Accurate identification of prodromal PD is essential for precise clinical management, with multimodal imaging features playing a key role in its detection and personalized treatment. This paper examines the clinicopathological features of prodromal PD, analyzes current diagnostic frameworks and risk assessment strategies, describes multimodal imaging characteristics, and reviews artificial intelligence (AI) applications in its diagnosis and prognostic prediction. It also identifies limitations of current research and proposes future directions, to provide radiologists with imaging references for enhancing early diagnosis, treatment optimization and personalized risk assessment of prodromal PD. ]]></description>
<pubDate>Fri,20 Mar 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Application and progress of nigral imaging in the early diagnosis of Parkinson<sup><sup>,</sup></sup>s disease]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.03.022</link>
<description><![CDATA[Parkinson<sup><sup>,</sup></sup>s disease (PD) is one of the most prevalent neurodegenerative disorders, primarily characterized by the loss of dopaminergic neurons in the substantia nigra pars compacta. Early diagnosis of PD is crucial for timely therapeutic intervention and improved clinical outcomes. MRI, as a non-invasive imaging modality, has shown great promise in the early detection of PD, particularly in evaluating structural and functional alterations in the substantia nigra. This review highlights four representative MRI techniques used to assess the substantia nigra in early-stage PD: Nigrosome imaging, neuromelanin-sensitive MRI, quantitative susceptibility mapping, and diffusion tensor imaging. We systematically discuss the imaging principles, recent research advancements, and the diagnostic performance and limitations of each technique in detecting early PD. Moreover, we explore the utility of these imaging approaches in the differential diagnosis of atypical Parkinsonian syndromes. Finally, we outline potential future research directions and clinical applications, aiming to provide theoretical foundations and technical support for advancing the early diagnosis of PD. ]]></description>
<pubDate>Fri,20 Mar 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Research progress of multimodal magnetic resonance imaging in occupational manganese exposure-induced neurotoxicity]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.03.023</link>
<description><![CDATA[Chronic manganese exposure can adversely affect the central nervous system, resulting in motor and cognitive impairments. Advances in neuroimaging have enabled multimodal MRI to sensitively and non-invasively characterize structural, functional, and metabolic brain alterations in manganese-exposed individuals, even at early and subclinical stages. These imaging findings provide critical insights into the neurobiological mechanisms underlying manganese-induced neurotoxicity. This review synthesizes current evidence on the application of multiple MRI modalities in occupational manganese exposure, focusing on their ability to detect microstructural damage, functional network alterations, and potential imaging biomarkers. It also summarizes the current limitations of these studies and outlines future research directions, aiming to support mechanistic interpretation, early identification of manganese-related neural injury, and improved imaging-based risk assessment in occupational settings. ]]></description>
<pubDate>Fri,20 Mar 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Research progress of MRI radiomics in differential diagnosis and prognostic evaluation of primary central nervous system lymphoma]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.03.024</link>
<description><![CDATA[Primary central nervous system lymphoma (PCNSL) is an aggressive extranodal lymphoma that remains clinically rare. Owing to its highly invasive tumor biology and the fact that therapeutic options are constrained by the blood–brain barrier, patients with PCNSL exhibit markedly poor overall prognosis, making PCNSL one of the most challenging lymphoma subtypes in contemporary clinical oncology. Although MRI is now widely used for the diagnosis and grading of central nervous system tumors, the underlying molecular mechanisms, tumor microenvironment, and biological processes within the lesions still require further exploration. Radiomics can mine deeper information from the tumor, enabling more objective and comprehensive assessment of tumor heterogeneity, and has shown great potential for diagnosis, grading, and prognosis prediction across various cancers. This review focuses on the latest applications and research advances of MRI-based radiomics in the diagnosis and prognostic prediction of PCNSL, highlights current limitations, and outlines future research directions, aiming to further advance the field. ]]></description>
<pubDate>Fri,20 Mar 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Application and progress of multimodal imaging technology in carotid atherosclerotic disease]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.03.025</link>
<description><![CDATA[Ischemic stroke caused by atherosclerosis is a major cause of disability and death globally. Carotid atherosclerosis, as one of the primary causes of ischemic stroke episodes, is particularly important for early prevention, diagnosis, assessment, and selection of treatment methods. Currently, research on carotid atherosclerosis has shifted from traditional lumen stenosis assessment to focusing on comprehensive risk stratification, such as plaque vulnerability and hemodynamics. However, there is still a lack of systematic organization regarding the clinical application integration, standardized interpretation, and how to apply these technologies to guide individualized treatment. This article reviews the multimodal imaging assessment, novel risk factors, plaque scoring, and surgical treatment progress of carotid atherosclerosis. It focuses on the application of advanced imaging technologies, such as high-resolution magnetic resonance vascular wall imaging, computational fluid dynamics, and 4D-flow MRI, in plaque composition analysis, hemodynamic assessment, and plaque risk stratification. It also points out the limitations of current related research in clinical application and analyzes feasible future research directions. This article aims to integrate multimodal imaging technology with individualized treatment strategies, indicating new directions for related research and contributing to achieving precise diagnosis and treatment. ]]></description>
<pubDate>Fri,20 Mar 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Research progress of intravoxel incoherent motion MRI in the diagnosis and treatment of nasopharyngeal carcinoma]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.03.026</link>
<description><![CDATA[Nasopharyngeal carcinoma (NPC) is one of the most prevalent head and neck malignancies in China. Although NPC is sensitive to chemoradiotherapy and the 5-year overall survival rate has significantly improved due to the adoption of advanced radiotherapy equipment and multimodal treatment strategies, locoregional recurrence and distant metastasis remain the primary causes of treatment failure. Therefore, early, non-invasive, and accurate assessment is crucial for formulating individualized treatment plans and improving survival outcomes. Intravoxel incoherent motion (IVIM), a diffusion-weighted imaging technique capable of simultaneously measuring diffusion and perfusion, has demonstrated superior value compared to conventional diffusion-weighted imaging (DWI) in the evaluation of NPC. However, the predictive value of IVIM-derived parameters regarding treatment efficacy and prognosis remains a subject of controversy. Recently, IVIM-based radiomics and habitat analysis have partially addressed this limitation and enhanced the performance of predictive models by deeply characterizing tumor heterogeneity. This review summarizes the current applications of IVIM in the treatment evaluation, prognostic analysis, diagnosis, and differential diagnosis of NPC. It highlights the advantages and limitations of IVIM-derived parametric in these three aspects and delves into recent advances in radiomics and habitat analysis, with the aim of optimizing the individualized assessment system for NPC management. ]]></description>
<pubDate>Fri,20 Mar 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Research progress of cardiac magnetic resonance feature tracking technology in the assessment of multi-chamber strain in hypertrophic cardiomyopathy]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.03.027</link>
<description><![CDATA[Hypertrophic cardiomyopathy (HCM) is a common hereditary cardiomyopathy in clinical practice and one of the important causes of sudden cardiac death (SCD) in adolescents and young adults. Therefore, early identification and accurate assessment are crucial. Cardiac magnetic resonance feature tracking technology (CMR-FT) can non-invasively and quantitatively assess global myocardial strain based on conventional cine sequences, and has become a research hotspot in HCM cardiac function assessment in recent years. This review systematically expounds the basic principles, derivative parameters and advantages of CMR-FT, focusing on its core applications in the assessment of left and right ventricular, and left and right atrial strain in HCM, including early identification, obstruction phenotype differentiation, differential diagnosis, and risk stratification, etc. It clarifies the limitations such as insufficient technical standardization and analyzing the future development direction of multi-parameter model construction and artificial intelligence integration, so as to provide reference for the accurate clinical assessment of cardiac function and optimization of diagnosis and treatment strategies in HCM patients, and promote the integration of this technology into the whole-course management of HCM. ]]></description>
<pubDate>Fri,20 Mar 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Research progress on 4D Flow CMR in evaluating myocardial infarction]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.03.028</link>
<description><![CDATA[Myocardial infarction remains a leading cause of death worldwide, making the assessment of intracardiac hemodynamics essential for its diagnosis and management. Four-dimensional flow cardiac magnetic resonance (4D Flow CMR) has emerged as a promising non-invasive imaging technique capable of capturing comprehensive, multi-parametric, and dynamic blood flow information across the entire heart. Although increasingly applied in myocardial infarction research in recent years, a systematic synthesis of advances in this field is still lacking. This review focuses on the application of 4D Flow CMR in myocardial infarction, with emphasis on five key hemodynamic aspects: kinetic energy (KE) and flow components, vortex and vorticity analysis, pressure gradient quantification, myocardial blood flow (MBF), and pulse wave velocity (PWV). It summarizes the characteristic hemodynamic parameters revealed by this technology and discusses their clinical implications. Current limitations are also addressed, including prolonged scan times, complex post-processing, limited validation methods, and insufficient standardization. Future directions to facilitate clinical translation are highlighted, such as workflow automation, multi-center standardization, and integration with artificial intelligence. By systematically organizing the current evidence on 4D Flow CMR in hemodynamic evaluation related to myocardial infarction, this review aims to provide imaging-based support for early intervention, treatment response assessment, and prognostic evaluation, while offering a reference for further research and broader clinical adoption of the technology. ]]></description>
<pubDate>Fri,20 Mar 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Research progress of magnetic resonance imaging combined with artificial intelligence in the precision diagnosis and treatment of cervical cancer]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.03.029</link>
<description><![CDATA[Precision diagnosis and therapy for cervical cancer, a major global public health challenge, are hindered by tumor heterogeneity and the limitations of conventional assessment methods. The integration of artificial intelligence (AI) with multi-parametric MRI (mp-MRI) provides a new paradigm for non-invasively assessing tumor pathophysiology. Research in this field has established an AI-driven, hierarchical technical framework spanning from anatomical localization to molecular characterization: At the anatomical level, the introduction of novel architectures such as Transformer and state space models (SSM) has overcome the receptive field limitations of convolutional neural networks (CNN), achieving precise lesion segmentation within complex pelvic anatomical backgrounds. At the functional level, AI optimizes the parameter fitting models of intravoxel incoherent motion (IVIM), diffusion kurtosis imaging (DKI), and dynamic contrast-enhanced MRI (DCE-MRI) via deep neural networks (DNN), significantly enhancing the robustness of quantitative parameters. Furthermore, it utilizes habitat analysis techniques to quantify intra-tumoral microscopic heterogeneity for predicting lymph node metastasis (LNM) and lymphovascular space invasion (LVSI). At the molecular level, radiomics and radiogenomics leverage machine learning to deeply mine high-dimensional imaging features, establishing non-linear mappings between imaging phenotypes and molecular characteristics such as gene mutations and the immune microenvironment. Additionally, the integration of circulating tumor DNA (ctDNA) data facilitates the formation of a multi-modal "imaging biopsy" paradigm. This AI-empowered three-stage system (segmentation–functional analysis-molecular decoding) connects the entire chain of precision diagnosis and treatment for cervical cancer. However, the clinical translation of this system is still limited by systemic challenges such as inadequate data standardization, limited model generalizability, and poor interpretability. This article systematically reviews these advancements, deeply analyzes technical principles, clinical values, and practical dilemmas, aiming to provide a forward-looking perspective for promoting this technology towards clinically-oriented individualized precision medicine. ]]></description>
<pubDate>Fri,20 Mar 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Research progress on the application of T1 mapping and T2 mapping technology in gynecological malignant tumors]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.03.030</link>
<description><![CDATA[In recent years, the incidence of gynecological malignant tumors has been progressively increasing with a tendency toward younger age at onset. Magnetic resonance imaging (MRI), boasting high soft tissue resolution, multi-sequence, and multi-planar imaging capabilities, has been extensively employed in the diagnosis, staging, and prognostic evaluation of gynecological tumors. However, conventional magnetic resonance sequences cannot accurately capture the early pathophysiological changes in tumor tissues. As a core technical combination in the field of functional MRI, T1 mapping and T2 mapping techniques utilize their respective core quantitative parameters (T1 values and T2 values) to precisely reflect microcosmic pathophysiological changes in lesion tissues (e.g., water molecule distribution, protein binding status, and tissue perfusion) from the perspectives of longitudinal and transverse relaxation properties of tissues, respectively. These parameters serve as pivotal imaging biomarkers for deciphering tumor pathological characteristics, assessing disease progression, and monitoring treatment response. This review systematically summarizes the latest research advances of T1 mapping and T2 mapping techniques, comprehensively analyzes their application values in the differential diagnosis, staging and grading, efficacy monitoring, and prognostic evaluation of common gynecological malignant tumors (including cervical cancer, endometrial carcinoma, and ovarian cancer), and discusses the current limitations in research (e.g., prolonged scanning time, inadequate standardization, and artifact interference). Furthermore, it proposes future optimization directions, aiming to more comprehensively unravel the pathophysiological mechanisms of gynecological malignant tumors and provide novel insights and approaches for precise diagnosis and treatment research in this field. ]]></description>
<pubDate>Fri,20 Mar 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Research progress of deep learning combined with radiomics in musculoskeletal diseases]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.03.031</link>
<description><![CDATA[Musculoskeletal diseases are among the most prevalent and debilitating chronic conditions worldwide. With the acceleration of population aging, their incidence continues to rise, posing a major public health challenge. Conventional imaging-based diagnosis relies heavily on the subjective interpretation of clinicians and is limited by high inter-observer variability, insufficient sensitivity for early lesions, and a lack of robust quantitative assessment tools, making it difficult to meet the requirements of precision medicine. In recent years, the rapid development of deep learning and radiomics has provided new technical pathways for intelligent assessment and decision-making in musculoskeletal disorders. This review systematically summarizes the research progress of deep learning and radiomics in a range of musculoskeletal conditions, including osteoarthritis, osteoporosis and fragility fractures, bone tumors and benign-malignant differentiation, muscle diseases and muscle atrophy, as well as tendon and ligament injuries. We focus on their applications in automatic segmentation, computer-aided diagnosis, disease classification, progression prediction, treatment decision support, and prognostic evaluation, highlighting their potential advantages in improving diagnostic accuracy, enabling quantitative characterization of lesions, and supporting individualized therapeutic strategies. In addition, we outline the major challenges currently limiting clinical translation, such as insufficient data standardization, limited model interpretability, suboptimal multicenter generalizability, and uncertainties in implementation pathways. Finally, future research directions are discussed with the aim of providing methodological reference and theoretical support for early diagnosis, prognostic assessment, and precision treatment of musculoskeletal diseases based on deep learning and radiomics. ]]></description>
<pubDate>Fri,20 Mar 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[New progress in magnetic resonance imaging for evaluating ectopic fat deposition in type 2 diabetes mellitus]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.03.032</link>
<description><![CDATA[Type 2 diabetes mellitus (T2DM) has emerged as a significant global public health challenge. While obesity is traditionally considered a core risk factor, mounting evidence indicates that fat distribution patterns—specifically ectopic fat deposition (EFD) in visceral depots and key metabolic organs—play a more pivotal role in the pathophysiology of T2DM. Magnetic resonance imaging (MRI) and its advanced techniques, such as proton density fat fraction (PDFF) and magnetic resonance spectroscopy (MRS), provide powerful tools for the non-invasive and precise quantification of systemic and organ-specific fat content. Despite the established association between obesity and T2DM, traditional systemic obesity metrics fail to capture the high heterogeneity of EFD and its organ-specific pathogenic mechanisms. Current clinical assessments often lag behind microstructural organ damage and lack precise means to monitor these occult fat depots and their dynamic changes during treatment. To address this, this article reviews recent advances in using MRI to evaluate EFD in patients with T2DM. It focuses on fat distribution patterns, the evolution of quantitative MRI techniques, and the specific pathophysiological alterations induced by EFD in the liver, pancreas, skeletal muscle, heart, kidneys, and central nervous system. Furthermore, the review evaluates the clinical value of MRI in assessing the efficacy of therapeutic interventions, including lifestyle modifications, pharmacotherapy, and bariatric surgery. Finally, future research directions are discussed, with the aim of providing imaging-based references to support early precision subtyping and personalized management strategies for T2DM. ]]></description>
<pubDate>Fri,20 Mar 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Advances in quantitative MRI techniques for assessing lower extremity muscle in long-distance runners]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.03.033</link>
<description><![CDATA[Long-distance running, while enhancing cardiopulmonary fitness and promoting psychological well-being, frequently induces microtrauma and adaptive remodeling in the lower extremity musculature. Conventional imaging modalities exhibit limited sensitivity in evaluating early-stage muscle injury and microstructural alterations. In contrast, quantitative magnetic resonance imaging (qMRI) techniques, such as T2-mapping, diffusion tensor imaging (DTI), intravoxel incoherent motion (IVIM) imaging, fat quantification methods, magnetic resonance spectroscopy (MRS), and chemical exchange saturation transfer (CEST), enable non-invasive and objective assessment of muscle status by quantifying specific biophysical and biochemical parameters. These advanced MRI approaches sensitively detect exercise-induced microstructural perturbations, delineate their spatiotemporal dynamics, and provide critical insights for injury prevention, individualized rehabilitation strategies, and evaluation of training efficacy. However, current research on the application of qMRI in assessing lower limb muscles in long-distance runners still has limitations such as small sample sizes, lack of long-term follow-up, and predominantly cross-sectional designs, resulting in insufficient understanding of spatiotemporal dynamic changes. Therefore, a systematic review is necessary to integrate existing evidence and identify research gaps. This article systematically reviews the current applications and advances of qMRI in characterizing post-exercise changes in lower limb muscles of long-distance runners, with a focus on muscle edema, microstructural integrity, perfusion status, intramuscular fat infiltration, and metabolic alterations, and analyzes the limitations in current research, proposes future research directions, in order to provide references for injury prevention in long-distance running, optimization of rehabilitation strategies, and research in sports medicine. ]]></description>
<pubDate>Fri,20 Mar 2026 00:00:00  GMT</pubDate>
</item>
</channel>
</rss>
